Postexposure prophylaxis: An intervention to prevent human immunodeficiency virus infection in adolescents

Current Opinion in Pediatrics

Volumn 15, Issue 4, 2003, Pages 379-384

  Olshen, Elyse ^a   Samples, Cathryn L ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ANTIVIRAL ACTIVITY; COUNSELING; DRUG EFFICACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; OCCUPATIONAL EXPOSURE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; RISK BENEFIT ANALYSIS; SEROCONVERSION; SEXUAL TRANSMISSION; VIRUS TRANSMISSION;

EID: 0041737634     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-200308000-00004     Document Type: Review

References (35)

1. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report 2001, 13:1-41. Available at http://www.cdcnpin.org
2. Centers for Disease Control and Prevention: Revised guidelines for HIV counseling, testing and referral. MMWR Morb Mortal Wkly Rep 2001, 50(RR1g):1-58.
3. Centers for Disease Control and Prevention: Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV and HIV and recommendations for post-exposure prophylaxis. MMWR Morb Mortal Wkly Rep 2001, 50(RR11):1-50.
4. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the US. August, 2002. Available at: http://www.aidsinfo.nih.gov/guidelines/perinatal\Perinatal.pdf This is the most recent guideline for prevention of perinatal transmission: It contains a review of the rationale and literature and summaries of U.S. and international research in this area.
5. Black RJ: Animal studies of prophylaxis. Am J Med 1997, 102(5B):39-44.
6. Conner EM, Sperling RS, Gelber R, et al: Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994, 331:1173-1180.
7. Tokars JI, Marcus R, Culver DH, et al: Surveillance of HIV infection and zidovudine use among health care workers after occupational exposure to HIV-infected blood. Ann Intern Med 1993, 118:913-919.
8. Cardo DM, Culver DH, Ciesielski CA, et al: A case-control study of HIV seroconversion in health care workers after percutaneous exposure. N Engl J Med 1997, 337:1485-1490.
9. Katz MH, Geberding JL: Postexposure treatment of people exposed to the human immunodeficiency virus though sexual contact or injection-drug use. N Engl J Med 1997, 336:1097-1100.
10. Mastro TD, de Vicenzi I: Probabilities of sexual HIV-1 transmission. AIDS 1996, 10(suppl A):S75-S82
11. Dillon B, Hecht FM, Swanson M, et al: Primary HIV infections associated with oral transmission. Paper presented at the 7th Conference on Retroviruses and Opportunistic Infections, February 2000, San Francisco, CA. Available at: http://www.retroconference.org/2000/abstracts/473.htm
12. Wawer MJ, Serwadda D, Li X, et al: HIV-1 transmission per coital act, by stage of HIV infection in the HIV+ index partner, in discordant couples, Rakai, Uganda. Paper presented at the 10th Conference on Retroviruses and Opportunistic Infections, February 2003, Boston, MA. Available at: http://www.retroconference.org/2003/Abstract/search.aspx
13. Schechter M, Ismerio R, Mendelsohn AB, et al: Acceptability, behavioral impact, and possible efficacy of post-sexual-exposure chemoprohylaxis (PEP) for HIV. Paper presented at the 9th Conference on Retroviruses and Opportunistic Infections, February 2002, Seattle, WA. Available at: http://www.retroconference.org/2002/Abstract/13050.htm First and only study to date to demonstrate the efficacy of NPEP in a cohort of high-risk men.
14. Wuffsohn A, Venter WDF, Schultze D, et al: Post-exposure prophylaxis after sexual assault in South Africa. Paper presented at the 10th Conference on Retroviruses and Opportunistic Infections, February 2003, Boston, MA. Available at: http://www.retroconference.org/2003/Abstract/search.aspx This recently presented paper is one South African hospital's experience with offering NPEP to all victims of sexual assault. Follow-up rates were low, and there is no information on adherence.
15. Braitstein P, Chan K, McLeod A, et al: Safety and tolerability of combination antiretroviral post-exposure prophylaxis in a population-based setting. J Acquir Immune Defic Syndr 2002, 29:547-548. Interesting report on adverse effects associated with PEP.
16. Laporte A, Jourdan N, Bouvet E, et al: Post-exposure prophylaxis after non-occupational HIV exposure: impact of recommendations on physicians' experiences and attitudes. AIDS 2002, 16:397-405. Informative report on physician practice with NPEP in France.
17. Parkin JM, Murphy M, Anderson J, et al: Tolerability and side-effects of post-exposure prophylaxis for HIV infection. Lancet 2000, 355:722-723.
18. Martin JN, Roland ME, Bamberger JD, et al. Post-exposure prophylaxis (PEP) for sexual exposure to HIV does not lead to increases in high risk behavior: The San Francisco PEP project. Paper presented at the 8th Conference on Retroviruses and Opportunistic Infections, February 2001, Chicago, IL. Available at: http://www.retroconference.org/2001/abstracts/abstracts/abstracts/224.htm
19. Khan JO, Martin JN, Roland ME, et al: Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: The San Francisco PEP study. J Infect Dis 2001, 183:707-714.
20. Li RW, Wong JB: Postexposure treatment of HIV. N Engl J Med 1997, 337:499-501.
21. Pinkerton SD, Holtgrave DR, Bloom FR: Cost-effectiveness of post-exposure prophylaxis following sexual exposure to HIV. AIDS 1998, 12:1067-1078.
22. Merchant RC, Kesharavarz RK: Human immunodeficiency virus postexposure prophylaxis for adolescents and children. Pediatrics 2001, 108:E38.
23. Babl FE, Cooper ER, Damon B, et al: HIV postexposure prophylaxis for children and adolescents. Am J Emerg Med 2000, 18:282-287.
24. Neu N, Heffernan S, Brown J, et al: Pediatric and adolescent HIV prophylaxis after sexual assault. Paper presented at the 7th Conference on Retroviruses and Opportunistic Infections, February 2000, San Francisco, CA. Available at: http://www.retroconference.org/2000/abstracts/4911.htm
25. Limb S, Kawsar M, Forster GE: HIV post-exposure prophylaxis after sexual assault: the experience of a sexual assault service in London. Int J STD AIDS 2002, 13:602-605.
26. Giele CM, Maw R, Carne CA, et al: Post-exposure prophylaxis for non-occupational exposure to HIV: current clinical practice and opinions in the UK. Sex Transm Infect 2002, 78:130-132.
27. Greub G, Gallant S, Zurn P, et al: Spare non-occupational HIV post-exposure prophylaxis by active contacting and testing of the source person. AIDS 2002, 16:1171-1176. Provocative study on the benefits of rapid source testing. This topic merits further study.
28. Centers for Disease Control and Prevention: Approval of a new rapid test for HIV antibody. MMWR Morb Mortal Wkly Rep 2002, 51:1051-1052. Exciting advance in HIV testing that may change how we prescribe NPEP.
29. Stephenson J: PEP talk: treating nonoccupational HIV Exposure. JAMA 2003, 289:287-288. Excellent brief review of PEP.
30. Centers for Disease Control and Prevention: Management of possible sexual, injecting-drug-use, or other nonoccupational exposure to HIV, including considerations related to antiretroviral therapy public health service statement. MMWR Morb Mortal Wkly Rep 1998, 47(RR17):1-14.
31. AIDS Institute: HIV prophylaxis following sexual assault: Guidelines for Adults and Adolescents. New York, NY: AIDS Institute, New York State Department of Health 1998. Available at: http://www.hivguidelines.org/public_html/center/clinicalguidelines/ pep_guidelines/pep_guidelines.htm
32. Myles JE, Bamberger J: Offering HIV prophylaxis following sexual assault: recommendations for the state of California. California HIV postexposure prophylaxis after sexual assault task force, 2001. Available at: http://www.dhs.ca.gov/ps/ooa/Reports/PDF/HIVProphylaxisFollowingSexualAssault. pdf
33. Weinberg G: Postexposure prophylaxis against human immunodeficiency virus infection after sexual assault. Pediatr Infect Dis J 2002, 21:959-960.
34. Koh HK, DeMaria A, McGuire JF. Massachusetts Clinical Advisory, Massachusetts, 2001. Available at http:/www.state.ma.us/dph/aids/guidelines/exposure_nonwork.htm
35. Merchant RC, Mayer KH, Browning CA: Nonoccupational HIV post-exposure prophylaxis: guidelines for Rhode Island from the Brown University AIDS Program and the RI Department of Health. Med Health RI 2002, 85:244-248. Available at: http://www.healthri.org/media/020925a.htm Most up-to-date and thorough guidelines on NPEP available.